Summary

Market Overview
The Global Blood Transfusion Devices Market is projected to grow from USD 4.97 Billion in 2025 to USD 6.97 Billion by 2031 at a 5.8% CAGR. These specialized medical tools, which include access catheters, tubing, and filters, are engineered to enable the secure and regulated intravenous delivery of blood and its components from donors to patients. Market growth is largely fueled by the rising worldwide frequency of trauma incidents, surgeries, and chronic illnesses that rely on transfusions. Additionally, the growing rates of health issues requiring repeated blood transfusions, like kidney disease, cancer, and anemia, play a major role in driving the industry forward. Notably, an abstract from the AABB 2025 Annual Meeting highlighted that overall institutional transfusions of packed red blood cells in 2024 maintained a decrease of roughly 15-23% against the 2019 baseline of 11,850 units.
A major hurdle hindering the growth of this market is the high operational and capital expenditure tied to sophisticated transfusion technologies. Such hefty costs often act as a financial obstacle to the implementation of these devices, especially in low- and middle-income nations, consequently restricting global access to state-of-the-art transfusion treatments.
Market Driver
A major factor propelling the need for blood transfusion equipment is the rising number of surgical operations, given that many lengthy and complex medical interventions depend on transfusions to control bleeding and keep patients stable. Improved surgical methods and broader healthcare accessibility have led to a consistent global increase in the number of surgeries performed. Highlighting this trend, a November 2025 systematic review in PMC projected that by 2050, Total Hip Arthroplasty (THA) procedures could surge by 121% to over 200%, while Total Knee Arthroplasty (TKA) operations are anticipated to grow by a minimum of 130% internationally, emphasizing the ongoing expansion of treatments that regularly require blood support.
Additionally, the escalating rates of chronic illnesses and blood disorders serve as a core catalyst for the expansion of the blood transfusion devices industry. Illnesses like sickle cell disease, severe anemia, thalassemias, and specific types of cancer often depend on periodic or routine blood transfusions for effective patient care. The Global footprint of these health issues is immense, with the World Health Organization's 2025 anemia report indicating that 30.7% of women between 15 and 49 years old experienced anemia in 2023. This ongoing requirement for blood directly accelerates the need for highly effective transfusion tools, even as the American Red Cross reported a 35% drop in the national blood supply in January 2026 compared to the previous month, underscoring severe constraints on the availability of transfusable blood.
Market Challenge
The heavy financial burden regarding both capital and operational expenses for cutting-edge transfusion technologies poses a major obstacle to the expansion of the Global Blood Transfusion Devices Market. These steep costs create fiscal roadblocks for medical facilities, disproportionately lowering adoption rates in low- and middle-income nations. The steep upfront costs needed to procure advanced machinery, combined with continuous maintenance and running fees, severely restrict the capacity of numerous healthcare institutions to purchase or upgrade to contemporary transfusion systems.
Such economic pressures directly slow down market growth by limiting buyers' financial flexibility and postponing the adoption of new technologies. Highlighting this issue, an abstract from the AABB 2025 Annual Meeting revealed that a hospital system's overall expenditure on blood products surged by 19.8%, climbing from $12.8 million in 2020 to $15.3 million in 2024. The escalating operational costs associated with acquiring blood products subsequently shrink the funds available for investing in updated blood transfusion equipment, ultimately hindering market reach and the global deployment of advanced medical systems.
Market Trends
The rising integration of automation within blood collection and processing equipment is a central industry trend, serving to boost productivity and reduce human error during blood product preparation. This shift significantly impacts the sector by generating demand for sophisticated, automated technologies that optimize laboratory operations and increase the precision of sample management. Demonstrating this benefit, an abstract from the AABB 2025 Annual Meeting detailed how a major academic and research hospital saved roughly two hours of a technologist's time per cycle during red blood cell antigen testing by utilizing an automated immunohematology analyzer. These improvements in efficiency are essential for transfusion centers and blood banks needing to process growing quantities of blood products rapidly and reliably.
At the same time, the rising adoption of point-of-care and home-based transfusion equipment highlights a major evolution in medical care, bringing blood administration directly into the patient's immediate environment rather than relying solely on conventional clinical facilities. This movement broadens the reach of transfusion treatments, especially for individuals who need rapid or recurring care. As a result, the industry is seeing a surge in requests for intuitive, portable instruments that can securely and efficiently deliver blood components across various non-hospital environments. Supporting this shift, America's Blood Centers reported in February 2026 that new national statistics on prehospital transfusions confirm these critical interventions are frequently taking place before patients arrive at medical centers, underscoring the expanding role of transfusion equipment in home care and emergency situations.

Key Market Players
* Immucor Inc.
* Becton Dickinson and Company
* B. Braun Melsungen AG
* Terumo Corporation
* Grifols SA
* Kaneka Corporation
* Fresenius Kabi AG
* Haemonetics Corporation
* Macopharma SA
* Ecomed Solutions, LLC.

Report Scope
In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Blood Transfusion Devices Market, By Product
* Apheresis Systems
* Infusion Devices
* Blood Warmers
* Venous Access Devices
* Filters
* Others
# Blood Transfusion Devices Market, By End Use
* Hospital
* Ambulatory Surgical Centers
* Dialysis Centers
* Blood Bank
* Others
# Blood Transfusion Devices Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.
Available Customizations:
Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Blood Transfusion Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Blood Transfusion Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Transfusion Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By End Use
6.3.2. Canada Blood Transfusion Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By End Use
6.3.3. Mexico Blood Transfusion Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By End Use
7. Europe Blood Transfusion Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Blood Transfusion Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By End Use
7.3.2. France Blood Transfusion Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By End Use
7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By End Use
7.3.4. Italy Blood Transfusion Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By End Use
7.3.5. Spain Blood Transfusion Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By End Use
8. Asia Pacific Blood Transfusion Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Blood Transfusion Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By End Use
8.3.2. India Blood Transfusion Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By End Use
8.3.3. Japan Blood Transfusion Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By End Use
8.3.4. South Korea Blood Transfusion Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By End Use
8.3.5. Australia Blood Transfusion Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By End Use
9. Middle East & Africa Blood Transfusion Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By End Use
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Blood Transfusion Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By End Use
9.3.2. UAE Blood Transfusion Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By End Use
9.3.3. South Africa Blood Transfusion Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By End Use
10. South America Blood Transfusion Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By End Use
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Blood Transfusion Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By End Use
10.3.2. Colombia Blood Transfusion Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By End Use
10.3.3. Argentina Blood Transfusion Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Blood Transfusion Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Immucor Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Becton Dickinson and Company
15.3. B. Braun Melsungen AG
15.4. Terumo Corporation
15.5. Grifols SA
15.6. Kaneka Corporation
15.7. Fresenius Kabi AG
15.8. Haemonetics Corporation
15.9. Macopharma SA
15.10. Ecomed Solutions, LLC.
16. Strategic Recommendations
17. About Us & Disclaimer